November 05, 2018
Humana on Friday asked the Pennsylvania federal court overseeing the sprawling multidistrict litigation over generic drug prices to formally incorporate its action into the MDL, saying its claims target many of the same drugs that the group of states and proposed classes of drug buyers are targeting.
October 17, 2018
A Pennsylvania federal court has greenlighted the first round of multidistrict litigation accusing more than 20 generic-drug makers of conspiring to fix their prices, excusing only Teligent Inc. from the antitrust litigation.
September 26, 2018
McKesson Corp. earned billions of dollars by cooperating with an industrywide price-fixing conspiracy among generic-drug makers, according to a proposed class action Tuesday that appeared to be one of the first suits linking a drug distributor to multidistrict litigation over alleged drugmaker collusion.
January 03, 2018
Direct purchaser plaintiffs in a large antitrust class action alleging price-fixing of a variety of generic drugs are pushing back against a motion to dismiss claims over two drugs, telling a Pennsylvania federal judge that the complaints contain more than enough of a basis to open discovery.
November 15, 2017
State attorneys general accusing 18 drug companies of conspiring to fix the prices of 15 generic drugs urged a Pennsylvania federal judge Tuesday to establish a separate government track within the broader multidistrict litigation, saying they can't yield authority to other entities such as private parties' lead counsel and their allegations are too broad to be litigated drug by drug.
October 31, 2017
The 46 attorneys general accusing six drug companies of conspiring to fix the price of two generic drugs said Tuesday they're asking a Pennsylvania federal court for permission to massively expand their suit by targeting 12 more drug companies, 13 more drugs, and Mylan and Emcure executives.
June 02, 2017
Mylan Inc., Fougera Pharmaceuticals Inc., Par Pharmaceuticals Inc. and other drugmakers conspired to jack up the prices of certain generic muscle relaxers, skin creams, antidepressants and blood pressure drugs, a Northeast U.S. pharmacy operator said in six separate antitrust lawsuits filed on Thursday as part of multidistrict litigation in Pennsylvania federal court.
May 23, 2017
The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania's Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.